Pages that link to "Q34382527"
The following pages link to Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors (Q34382527):
Displaying 33 items.
- Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents (Q26744212) (← links)
- Potential use of histone deacetylase inhibitors in cancer therapy (Q26769594) (← links)
- Paradoxical regulation of hypoxia inducible factor-1α (HIF-1α) by histone deacetylase inhibitor in diffuse large B-cell lymphoma (Q28535447) (← links)
- Epigenetics: an expanding new piece of the stroke puzzle (Q33352309) (← links)
- Valproic acid treatment inhibits hypoxia-inducible factor 1α accumulation and protects against burn-induced gut barrier dysfunction in a rodent model (Q35023191) (← links)
- Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapy (Q35108007) (← links)
- The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes (Q35115789) (← links)
- DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas. (Q35233163) (← links)
- AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol (Q36186609) (← links)
- Glioma revisited: from neurogenesis and cancer stem cells to the epigenetic regulation of the niche (Q36225175) (← links)
- Regulators of gene expression as biomarkers for prostate cancer (Q36439912) (← links)
- Hypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells (Q36470446) (← links)
- Emerging molecular targets for brain repair after stroke (Q36567408) (← links)
- Environmental exposures, epigenetics and cardiovascular disease (Q37091471) (← links)
- The apoptotic effects of sirtuin1 inhibitor on the MCF-7 and MRC-5 cell lines. (Q37150846) (← links)
- Combination of Salermide and Cholera Toxin B Induce Apoptosis in MCF-7 but Not in MRC-5 Cell Lines (Q37503038) (← links)
- Erasers of histone acetylation: the histone deacetylase enzymes (Q37673993) (← links)
- Epigenetics: new questions on the response to hypoxia (Q37918376) (← links)
- Roles for HIF-1α in neural stem cell function and the regenerative response to stroke. (Q37922875) (← links)
- Modulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective (Q37943792) (← links)
- The therapeutic potential of epigenetics in autoimmune diseases. (Q37967566) (← links)
- Suffocating cancer: hypoxia-associated epimutations as targets for cancer therapy (Q37993229) (← links)
- Epigenetics within the matrix: a neo-regulator of fibrotic disease (Q38034837) (← links)
- The potential role of HIF on tumour progression and dissemination. (Q38204343) (← links)
- Hypoxia in diabetic kidneys (Q38233058) (← links)
- Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition (Q38748006) (← links)
- Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals (Q38788965) (← links)
- Evaluation of melanogenesis in A-375 melanoma cells treated with 5,7-dimethoxycoumarin and valproic acid. (Q39273391) (← links)
- Sodium butyrate enhances the growth inhibitory effect of sunitinib in human renal cell carcinoma cells (Q40979307) (← links)
- Histone deacetylase inhibitors promote eNOS expression in vascular smooth muscle cells and suppress hypoxia-induced cell growth (Q41520325) (← links)
- Anti-inflammatory properties of histone deacetylase inhibitors: a mechanistic study (Q42969769) (← links)
- Single-cell assessment of transcriptome alterations induced by Scriptaid in early differentiated human haematopoietic progenitors during ex vivo expansion (Q64109266) (← links)
- Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines (Q96765712) (← links)